The HelpED Study: Agreement and Impact of the Erection Hardness Score on Sexual Function and Psychosocial Outcomes in Men with Erectile Dysfunction and Their Partners
Hubert I.M. Claes MD, PhD,
Robert Andrianne MD, PhD,
Reinier Opsomer MD,
Adelin Albert PhD,
Seema Patel MPharm,
Kathleen Commers PharmD,
Corresponding Author
Hubert I.M. Claes MD, PhD
Department of Urology, University Clinics Gasthuisberg, Leuven, Belgium
Hubert I.M. Claes, MD, PhD, Department of Urology, University Clinics Gasthuisberg, Herestraat 49, B3000 Leuven, Belgium. Tel: +32 (16) 34-66-87; Fax: +32 (16) 26 10-83; E-mail: [email protected]Search for more papers by this authorRobert Andrianne MD, PhD
Department of Urology, CHU Sart-Tilman, Liège, Belgium
Search for more papers by this authorReinier Opsomer MD
Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Search for more papers by this authorAdelin Albert PhD
University of Liège, Medical Informatics and Biostatistics, Liège, Belgium
Search for more papers by this authorSeema Patel MPharm
Medical Department, Pfizer, Walton Oaks, Tadworth, UK
Search for more papers by this authorHubert I.M. Claes MD, PhD,
Robert Andrianne MD, PhD,
Reinier Opsomer MD,
Adelin Albert PhD,
Seema Patel MPharm,
Kathleen Commers PharmD,
Corresponding Author
Hubert I.M. Claes MD, PhD
Department of Urology, University Clinics Gasthuisberg, Leuven, Belgium
Hubert I.M. Claes, MD, PhD, Department of Urology, University Clinics Gasthuisberg, Herestraat 49, B3000 Leuven, Belgium. Tel: +32 (16) 34-66-87; Fax: +32 (16) 26 10-83; E-mail: [email protected]Search for more papers by this authorRobert Andrianne MD, PhD
Department of Urology, CHU Sart-Tilman, Liège, Belgium
Search for more papers by this authorReinier Opsomer MD
Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Search for more papers by this authorAdelin Albert PhD
University of Liège, Medical Informatics and Biostatistics, Liège, Belgium
Search for more papers by this authorSeema Patel MPharm
Medical Department, Pfizer, Walton Oaks, Tadworth, UK
Search for more papers by this authorABSTRACT
Introduction. The HelpED study assessed men with erectile dysfunction (ED) treated with a phosphodiesterase type 5 (PDE5) inhibitor and their female partner in a community setting.
Aim. To examine agreement in Erection Hardness Score (EHS) in patients and partners; to assess impact of EHS changes on other sexual health outcomes and behaviors.
Methods. At baseline and follow-up 2 to 4 months later, men in a stable heterosexual relationship who had newly diagnosed or untreated ED (≥6 months) completed the single-item EHS, the International Index of Erectile Function questions 4 and 5 (assessing erection maintenance), the Self-Esteem And Relationship (SEAR) questionnaire, and a modified Quality of Life domain of the Sexual Life Quality Questionnaire (mSLQQ-QOL). Partners completed the EHS, Female Sexual Function Index, and the mSLQQ-QOL.
Main Outcome Measures. EHS agreement assessed by Cohen weighted kappa coefficient, associations between change in EHS and change in measures of sexual function and quality of life; outcomes stratified by patient age (≤55 years vs. >55 years).
Results. Questionnaires were completed by 447 men (64% aged 51–70 years) and 253 partners (52% aged 46–60 years) at baseline and by 266 and 152, respectively, at follow-up. At baseline, the consulting physician proposed PDE5 inhibitor treatment for 99% of patients, and EHS mean values were similar in patients and partners. All outcomes improved significantly (P < 0.05), including EHS in 75% of men (EHS3 [hardness sufficient for sexual intercourse but not fully hard] improved to EHS4 [fully hard erection] in almost 60%). For most other outcomes, improvement was greater in younger men and in those who improved from EHS3 to EHS4.
Conclusions. Strong agreement in EHS between patient and partner and associations between improvement in EHS and improvements in measures of sexual function and quality of life in patients and partners support its clinical use in ED management. Claes HIM, Andrianne R, Opsomer R, Albert A, Patel S, and Commers K. The HelpED Study: Agreement and impact of the erection hardness score on sexual function and psychosocial outcomes in men with erectile dysfunction and their partners. J Sex Med **;**:**–**.
References
- 1 Hedon F. Anxiety and erectile dysfunction: A global approach to ED enhances results and quality of life. Int J Impot Res 2003; 15: S16–9.
- 2 Dennerstein L, Lehert P, Burger H, Dudley E. Factors affecting sexual functioning of women in the mid-life years. Climacteric 1999; 2: 254–62.
- 3 Cayan S, Bozlu M, Canpolat B, Akbay E. The assessment of sexual functions in women with male partners complaining of erectile dysfunction: Does treatment of male sexual dysfunction improve female partner's sexual functions? J Sex Marital Ther 2004; 30: 333–41.
- 4 Dunn KM, Croft PR, Hackett GI. Satisfaction in the sex life of a general population sample. J Sex Marital Ther 2000; 26: 141–51.
- 5
Heiman JR,
Talley DR,
Bailen JL,
Oskin TA,
Rosenberg SJ,
Pace CR,
Creanga DL,
Bavendam T.
Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: A multicentre, randomised, double-blind, placebo-controlled trial.
Br J Obstet Gynaecol
2007; 114: 443–7.
10.1111/j.1471-0528.2006.01228.x Google Scholar
- 6 Chevret M, Jaudinot E, Sullivan K, Marrel A, De Gendre AS. Impact of erectile dysfunction (ED) on sexual life of female partners: Assessment with the Index of Sexual Life (ISL) questionnaire. J Sex Marital Ther 2004; 30: 157–72.
- 7 Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005; 2: 675–84.
- 8 O'Leary MP, Althof SE, Cappelleri JC, Crowley A, Sherman N, Duttagupta S. Self-esteem, confidence and relationship satisfaction of men with erectile dysfunction treated with sildenafil citrate: A multicenter, randomized, parallel group, double-blind, placebo controlled study in the United States. J Urol 2006; 175: 1058–62.
- 9 Seftel AD, Buvat J, Althof SE, McMurray JG, Zeigler HL, Burns PR, Wong DG. Improvements in confidence, sexual relationship and satisfaction measures: Results of a randomized trial of tadalafil 5 mg taken once daily. Int J Impot Res 2009; 21: 240–8.
- 10 Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Goldstein I, Bangerter K, Bandel TJ, Derogatis LR, Sand M. Improving the sexual quality of life of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005; 2: 699–708.
- 11 Rosen R, Goldstein I, Huang XY, Bangerter K, Taylor T. The Treatment Satisfaction Scale (TSS) is a sensitive measure of treatment effectiveness for both patients and partners: Results of a randomized controlled trial with vardenafil. J Sex Med 2007; 4: 1009–21.
- 12 Aubin S, Heiman JR, Berger RE, Murallo AV, Yung-Wen L. Comparing sildenafil alone vs. sildenafil plus brief couple sex therapy on erectile dysfunction and couples' sexual and marital quality of life: A pilot study. J Sex Marital Ther 2009; 35: 122–43.
- 13 DiBenedetti DB, Gondek K, Sagnier PP, Kubin M, Marquis P, Keininger D, Fugl-Meyer AR. The treatment satisfaction scale: A multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol 2005; 48: 503–11.
- 14 Edwards D, Hackett G, Collins O, Curram J. Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): A randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naive men with ED and their partners. J Sex Med 2006; 3: 1028–36.
- 15 Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Bangerter K, Bandel TJ, Derogatis LR. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: A prospective, randomized, double-blind, placebo-controlled trial. J Sex Med 2005; 2: 819–32.
- 16 Rubio-Aurioles E, Kim ED, Rosen RC, Porst H, Burns P, Zeigler H, Wong DG. Impact on erectile function and sexual quality of life of couples: A double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med 2009; 6: 1314–23.
- 17 Martin-Morales A, Graziottin A, Jaoude GB, Debruyne F, Buvat J, Beneke M, Neuser D. Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: A randomized, double-blind, placebo-controlled study. J Sex Med 2011; 8: 2831–40.
- 18 McCabe MP, O'Connor EJ, Conaglen JV, Conaglen HM. The impact of oral ED medication on female partners' relationship satisfaction. J Sex Med 2011; 8: 479–83.
- 19 Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples II: Association of female partner characteristics with male partner ED treatment seeking and phosphodiesterase type 5 inhibitor utilization. J Sex Med 2009; 6: 3111–24.
- 20 Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R, Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191–208.
- 21 Isidori AM, Pozza C, Esposito K, Giugliano D, Morano S, Vignozzi L, Corona G, Lenzi A, Jannini EA. Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction. J Sex Med 2010; 7: 1139–46.
- 22 Jannini EA, DeRogatis LR, Chung E, Brock GB. How to evaluate the efficacy of the phosphodiesterase type 5 inhibitors. J Sex Med 2012; 9: 26–33.
- 23 Jardin A, Wagner G, Khoury S. Recommendations of the 1st International Consultation on Erectile Dysfunction. Paris, France: Co-sponsored by the World Health Organization (WHO), International Consultation on Urological Diseases (ICUD) and Societe Internationale d'Urologie (SIU). 1999.
- 24 Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–30.
- 25 Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–26.
- 26 Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K. Validation of the Erection Hardness Score (EHS). J Sex Med 2007; 4: 1626–34.
- 27 Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397–404.
- 28 Mulhall JP, Levine LA, Jünemann KP. Erection hardness, a unifying factor for defining response in the treatment of erectile dysfunction. Urology 2006; 68: 17–25.
- 29 Goldstein I, Mulhall JP, Bushmakin AG, Cappelleri JC, Hvidsten K, Symonds T. The Erection Hardness Score and its relationship to successful sexual intercourse. J Sex Med 2008; 5: 2374–80.
- 30 Kadioglu A, Grohmann W, Depko A, Levinson I, Sun F, Collins S, for the multicenter study group. Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: Multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase. J Sex Med 2008; 5: 726–34.
- 31 Cappelleri JC, Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S. Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res 2004; 16: 30–8.
- 32 Woodward J, Hass S, Woodward P. Reliability and validity of the sexual life quality questionnaire (SLQQ). Qual Life Res 2002; 11: 365–77.
- 33 Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
- 34 McCammon KA, Kolm P, Main B, Schellhammer PF. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999; 54: 509–16.
- 35 Rubio-Aurioles E, Sand M, Terrein-Roccatti N, Dean J, Longworth J, Eardley I, Brock G, Lee J, de Montis IA, Rampazzo-Bonaldo C. Female Assessment of Male Erectile dysfunction detection scale (FAME): Development and validation. J Sex Med 2009; 6: 2255–70.
- 36 Rosen RC, Fisher WA, Beneke M, Homering M, Evers T. The COUPLES-project: A pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment. BJU Int 2007; 99: 849–59.
- 37 Althof SE, Rubio-Aurioles E, Kingsberg S, Zeigler H, Wong DG, Burns P. Impact of tadalafil once daily in men with erectile dysfunction—including a report of the partners' evaluation. Urology 2010; 75: 1358–63.
- 38 Althof SE, Eid JF, Talley DR, Brock GB, Dunn ME, Tomlin ME, Natanegara F, Ahuja S. Through the eyes of women: The partners' perspective on tadalafil. Urology 2006; 68: 631–5.
- 39 Montorsi F, Althof SE. Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction. Urology 2004; 63: 762–7.
- 40 Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples I: Couple conceptions of ED. J Sex Med 2009; 6: 2746–60.
- 41
Fisher WA,
Meryn S,
Sand M,
Brandenburg U,
Buvat J,
Mendive J,
Scott S,
Taylor A,
Torres LO.
Communication about erectile dysfunction among men with ED, partners of men with ED, and physicians: The Strike Up a Conversation Study (Part 1).
J Mens Health Gend
2005; 2: 64–78.
10.1016/j.jmhg.2005.01.018 Google Scholar
- 42 Mulhall JP, Althof SE, Brock GB, Goldstein I, Jünemann K-P, Kirby M. Erectile dysfunction: Monitoring response to treatment in clinical practice—recommendations of an international consensus panel. J Sex Med 2007; 4: 448–64.
- 43 Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Scoring correspondence in outcomes related to erectile dysfunction treatment on a 4-point scale (SCORE-4). J Sex Med 2009; 6: 809–19.
- 44 Althof SE, Berner MM, Goldstein I, Claes HI, Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology. J Sex Med 2010; 7: 3170–8.
- 45 Chevret-Measson M, Lavallee E, Troy S, Arnould B, Oudin S, Cuzin B. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: Findings of the Index of Sexual Life (ISL) in a couple study. J Sex Med 2009; 6: 761–9.
- 46 Mulhall J, King R, Glina S, Hvidsten K. Importance of and satisfaction with sex among men and women worldwide: Results of the Global Better Sex Survey. J Sex Med 2008; 5: 788–95.
- 47 Carson CC, Burnett AL, Levine LA, Nehra A. The efficacy of sildenafil citrate (Viagra®) in clinical populations: An update. Urology 2002; 60: 12–27.
- 48 Fujisawa M, Sawada K. Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction. Arch Androl 2004; 50: 255–60.
- 49 Tsujimura A, Yamanaka M, Takahashi T, Miura H, Nishimura K, Koga M, Iwasa A, Takeyama M, Matsumiya K, Takahara S, Okuyama A. The clinical studies of sildenafil for the ageing male. Int J Androl 2002; 25: 28–33.
- 50 Porst H, Young JM, Schmidt AC, Buvat J. Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups. Urology 2003; 62: 519–23.
